LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 80 filers reported holding LYELL IMMUNOPHARMA INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,003,889 | -54.1% | 1,363,190 | -0.7% | 0.00% | 0.0% |
| Q2 2023 | $4,366,833 | +33.0% | 1,373,218 | -1.3% | 0.00% | 0.0% |
| Q1 2023 | $3,283,723 | -26.6% | 1,391,408 | +8.0% | 0.00% | -50.0% |
| Q4 2022 | $4,471,189 | -42.4% | 1,288,527 | +21.6% | 0.00% | -33.3% |
| Q3 2022 | $7,769,000 | +20.6% | 1,059,897 | +7.3% | 0.00% | +50.0% |
| Q2 2022 | $6,442,000 | +28.1% | 988,109 | -0.7% | 0.00% | +100.0% |
| Q1 2022 | $5,027,000 | -32.9% | 995,531 | +2.8% | 0.00% | -50.0% |
| Q4 2021 | $7,493,000 | -48.1% | 968,065 | -0.7% | 0.00% | -50.0% |
| Q3 2021 | $14,433,000 | -10.0% | 975,190 | -1.3% | 0.00% | -20.0% |
| Q2 2021 | $16,044,000 | – | 987,928 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $69,963,292 | 35.72% |
| Orland Properties Ltd | 15,093,969 | $52,376,072 | 27.91% |
| Foresite Capital Management IV, LLC | 10,000,000 | $34,700,000 | 14.82% |
| MIC Capital Management UK LLP | 3,060,569 | $10,620,174 | 2.10% |
| Alphabet Inc. | 5,865,125 | $20,351,984 | 1.18% |
| HSG Holding Ltd | 3,045,997 | $10,569,610 | 1.07% |
| Artal Group S.A. | 700,000 | $2,429 | 0.14% |
| Eagle Health Investments LP | 100,000 | $347,000 | 0.08% |
| Virtus ETF Advisers LLC | 39,345 | $136,527 | 0.07% |
| BBR PARTNERS, LLC | 164,041 | $569,222 | 0.06% |